Risk factors of gastrointestinal bleeding in clopidogrel users: A nationwide population-based study

Alimentary Pharmacology and Therapeutics

Volumn 38, Issue 9, 2013, Pages 1119-1128

  Lin, C C ^a   Hu, H Y ^a,c   Luo, J C ^a,b   Peng, Y L ^a,b   Hou, M C ^a,b   Lin, H C ^a,b   Lee, F Y ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALENDRONIC ACID; CLOPIDOGREL; CYCLOOXYGENASE 2 INHIBITOR; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; STEROID; WARFARIN;

ADULT; AGE; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DATA BASE; DIABETES MELLITUS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEALTH INSURANCE; HELICOBACTER INFECTION; HUMAN; HYPERTENSION; LIVER CIRRHOSIS; LOWER GASTROINTESTINAL BLEEDING; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TAIWAN; UPPER GASTROINTESTINAL BLEEDING;

AGE FACTORS; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PEPTIC ULCER HEMORRHAGE; PLATELET AGGREGATION INHIBITORS; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; TAIWAN; TICLOPIDINE;

EID: 84885112693     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12483     Document Type: Article

References (23)

1. Luo JC,. Gastroprotective strategy in aspirin users. J Chin Med Assoc 2009; 72: 343-5.
2. Laine L,. Gastrointestinal bleeding with low-dose aspirin-what's the risk? Aliment Pharmacol Ther 2006; 24: 897-908. (Pubitemid 44326371)
3. Lanas A, Scheiman J,. Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention, and treatment. Curr Med Res Opin 2007; 23: 163-73. (Pubitemid 46201599)
4. CAPRIE Steering Committee. A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischemic events. Lancet 1996; 348: 1329-39.
5. Chan FK, Ching JY, Hung LC, et al,. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. N Engl J Med 2005; 352: 238-44. (Pubitemid 40110812)
6. Lai KC, Chu KM, Hui WM, et al,. Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications. Clin Gastroenterol Hepatol 2006; 4: 860-5.
7. Huang KW, Luo JC, Leu HB, et al,. Risk factors for upper gastrointestinal bleeding in coronary artery disease patients receiving both aspirin and clopidogrel. J Chin Med Assoc 2013; 76: 9-14.
8. Ng FH, Wong SY, Lam KF, et al,. Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions. Gastroenterology 2010; 138: 82-8.
9. Lanas A, García-Rodríguez LA, Arroyo MT, et al,. Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants. Am J Gastroenterol 2007; 102: 507-15. (Pubitemid 46328156)
10. Luo JC, Leu HB, Huang KW, et al,. Incidence of bleeding from gastroduodenal ulcers in patients with end-stage renal disease receiving hemodialysis. CMAJ 2011; 183: E1345-51.
11. Luo JC, Leu HB, Hou MC, et al,. Cirrhotics at increased risk of peptic ulcer bleeding: a nationwide population-based cohort study. Aliment Pharmacol Ther 2012; 36: 542-50.
12. Luo JC, Leu HB, Hou MC, et al,. Nonpeptic ulcer, nonvariceal gastrointestinal bleeding in hemodialysis patients. Am J Med 2013; 126: 264.e25-32.
13. Ng FH, Wong SY, Chang CM, et al,. High incidence of clopidogrel- associated gastrointestinal bleeding in patients with previous peptic ulcer disease. Aliment Pharmacol Ther 2003; 18: 443-9. (Pubitemid 37070243)
14. Bowry AD, Brookhart MA, Choudhry NK,. Meta-analysis of the efficacy and safety of clopidogrel plus aspirin as compared to antiplatelet monotherapy for the prevention of vascular events. Am J Cardiol 2008; 101: 960-6.
15. Luo JC, Huo TI, Hou MC, et al,. Clopidogrel delays gastric ulcer healing in rats. Eur J Pharmacol 2012; 695: 112-9.
16. Huang JQ, Sridhar S, Hunt RH,. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 2002; 359: 14-22. (Pubitemid 34119190)
17. Lanas A, García-Rodríguez LA, Arroyo MT, et al,.; Investigators of the Asociaciõn Española de Gastroenterología (AEG). Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants. Am J Gastroenterol 2007; 102: 507-15. (Pubitemid 46328156)
18. Hsu PI, Lai KH, Liu CP,. Esomeprazole with clopidogrel reduces peptic ulcer recurrence, compared with clopidogrel alone, in patients with atherosclerosis. Gastroenterology 2011; 140: 791-8.
19. Peng YL, Leu HB, Luo JC, et al,. Diabetes is an independent risk factor for peptic ulcer bleeding: a nationwide population-based cohort study J Gastroenterol Hepatol 2013; 28: 1295-9.
20. Labos C, Dasgupta K, Nedjar H, et al,. Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction. CMAJ 2011; 183: 1835-43.
21. Bon C, Aparicio T, Vincent M,., et al. Long-acting somatostatin analogues decrease blood transfusion requirements in patients with refractory gastrointestinal bleeding associated with angiodysplasia. Aliment Pharmacol Ther 2012; 36: 587-93.
22. Hreinsson JP, Gumundsson S, Kalaitzakis E, et al,. Lower gastrointestinal bleeding: incidence, etiology, and outcomes in a population-based setting. Eur J Gastroenterol Hepatol 2013; 25: 37-43.
23. Wu CY, Wu CH, Wu MS, et al,. A nationwide population-based cohort study shows reduced hospitalization for peptic ulcer disease associated with H. pylori eradication and proton pump inhibitor use. Clin Gastroenterol Hepatol 2009; 7: 427-31.